600252.SHG Guangxi Wuzhou Zhongheng Group Co Ltd

Healthcare Pharmaceuticals Shanghai Stock Exchange
2.24 CNY
Close of Nov 5, 2026
1.71 3.10
Market cap
CNY 7.13B
P/E
-
P/B
1.33x
ROE
-1.0%
Dividend yield
0.78%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 600252.SHG undervalued?

Graham number

The Graham number of Guangxi Wuzhou Zhongheng Group Co Ltd cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Guangxi Wuzhou Zhongheng Group Co Ltd fundamental analysis

No fundamental analysis for Guangxi Wuzhou Zhongheng Group Co Ltd yet.

Guangxi Wuzhou Zhongheng Group Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Guangxi Wuzhou Zhongheng Group Co Ltd

Guangxi Wuzhou Zhongheng Group Co., Ltd, together with its subsidiaries, researches, develops, manufactures, and sells pharmaceuticals in China. The company offers traditional Chinese medicine, including Xueshuantong injection, Zhonghua Dieda Wan for traumatic injuries, Fuyanjing capsules, JieShiTong tablets, snake gall and fritillaria liquid, Kunyuean granules, and compound clam oral liquid for cardiovascular and cerebrovascular, neurology, endocrinology, orthopedics, ophth…

Full company profile